Literature DB >> 7870980

Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration.

W A Carlezon1, R A Wise.   

Abstract

Phencyclidine (PCP; 2.5 or 5.0 mg/kg) potentiated the effects of rewarding hypothalamic brain stimulation, causing parallel leftward shifts of the functions that relate rate of responding to stimulation frequency. Thus, like a number of other drugs of abuse, PCP lowered the "dose" of stimulation required to maintain responding at a given criterion. No progressive changes in the reward-potentiating effects of PCP were evident when the rats were tested once per week for 8 weeks; there was neither tolerance nor sensitization to the initial rewarding properties of PCP. However, in subsequent locomotor tests rats appeared to be already sensitized to PCP; this raises the possibility that the electrical stimulation of the lateral hypothalamus itself maximally sensitized the animals to the stimulant effects of the drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870980     DOI: 10.1007/bf02253528

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

Review 1.  Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential.

Authors:  K M Johnson; S M Jones
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

2.  NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

Authors:  A Imperato; M G Scrocco; S Bacchi; L Angelucci
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

3.  Clinical observations in the treatment of adolescent and young adult PCP abusers.

Authors:  D H Fram; N Stone
Journal:  NIDA Res Monogr       Date:  1986

4.  Phencyclidine: changing abuse patterns.

Authors:  R Crider
Journal:  NIDA Res Monogr       Date:  1986

Review 5.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

Authors:  P W Kalivas; J Stewart
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

6.  Preexposure sensitizes rats to the rewarding effects of cocaine.

Authors:  B A Horger; K Shelton; S Schenk
Journal:  Pharmacol Biochem Behav       Date:  1990-12       Impact factor: 3.533

7.  Pimozide and amphetamine have opposing effects on the reward summation function.

Authors:  C R Gallistel; D Karras
Journal:  Pharmacol Biochem Behav       Date:  1984-01       Impact factor: 3.533

8.  The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity.

Authors:  A S Freeman; B S Bunney
Journal:  Eur J Pharmacol       Date:  1984-09-17       Impact factor: 4.432

9.  The effect of chronic cocaine on self-stimulation train-duration thresholds.

Authors:  R A Frank; S Martz; T Pommering
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

10.  Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.

Authors:  L Hernandez; S Auerbach; B G Hoebel
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

View more
  14 in total

1.  Food restriction enhances the central rewarding effect of abused drugs.

Authors:  S Cabeza de Vaca; K D Carr
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

Review 2.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

3.  Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Drug Dev Res       Date:  2014-10-15       Impact factor: 4.360

4.  Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex.

Authors:  W A Carlezon; R A Wise
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

5.  Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus.

Authors:  Laurence L Miller; Ahmad A Altarifi; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-08-10       Impact factor: 3.157

6.  Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus.

Authors:  Natashia Swalve; Scott T Barrett; Rick A Bevins; Ming Li
Journal:  Behav Brain Res       Date:  2015-05-27       Impact factor: 3.332

7.  Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

Authors:  R A Wise; E Munn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

8.  Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine.

Authors:  Jenny L Wiley; Amelia D Compton
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

9.  Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice.

Authors:  Ming-Huan Chan; Shiang-Sheng Chung; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Toxicol Appl Pharmacol       Date:  2012-10-12       Impact factor: 4.219

10.  NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala.

Authors:  Paul J Kenny; Elena Chartoff; Marisa Roberto; William A Carlezon; Athina Markou
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.